Bacterial cells use a plethora of mechanisms to evade antibiotic killing. A well-known strategy is antibiotic resistance, in which case the cells have acquired a genomic mutation enabling them to thrive in the presence of the antibiotic. In addition to resistance, every isogenic bacterial population harbours so-called persister cells. These persister cells are phenotypically different from their sensitive kin, and they can withstand even high doses of antibiotics. For a review on how and why persisters can evade antibiotic killing see Wilmaerts, Windels et al. (2019). The persister phenotype is only temporarily, and upon persister state exit, persisters re-initiate growth and are again susceptible to antibiotics.
In healthy patients, it is assumed that the immune system can clear the residing persister cells after antibiotic treatment. In immunocompromised patients, or in biofilm-associated infections, persister cells impose a threat as they result in the recolonization of the infection site. Indeed, the recurrence of several chronic infections, such as lung infections in cystic fibrosis patients, tuberculosis … is associated with the presence of persister cells (Fauvart et al. 2011).
In the Michiels lab, persistence of the model bacterium Escherichia coli and of the opportunistic human pathogen Pseudomonas aeruginosa has been studied for many years. Several research lines aim to detect key regulators of persistence, both in E. coli and in P. aeruginosa. Furthermore, these key regulators are subjected to further analysis with the aim of providing a better understanding of the underlying genetic and molecular mechanisms of persister formation (see e.g. Verstraeten, Knapen et al. 2015, Wilmaerts et al. 2018). Finally, we are interested in key regulators of persister state exit (see e.g. Wilmaerts et al. 2019). In addition to these fundamental research topics, we also try to combat chronic infections through translational research.
In another project, we perform evolution experiments to select for strains with high persistence levels. On the one hand, this helps us to unravel the genetic basis of persistence. On the other hand, it allows us to determine how persistence evolves in varying antibiotic treatment conditions (see e.g. Van den Bergh et al. 2016). We additionally use experimental evolution to investigate how persistence affects the emergence of genetic resistance (see e.g. Windels et al. 2019). The social-evolutionary impact of persistence is also studied within our group to gather a further fundamental understanding of this phenotype (see e.g. Stepanyan, Wenseleers et al. 2015).
Fauvart M., De Groote V., Michiels J. (2011). The role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. Journal of Medical Microbiology, 60(6):699-709.
Stepanyan K.#, Wenseleers T.#, Duenez-Guzman EA., Muratori F., Van den Bergh B., Verstraeten N., De Meester L., Verstrepen KJ., Fauvart M.*, Michiels J.* (2015). Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa. Molecular Ecology, 24(7):1572-1583.
Van den Bergh B., Michiels JE.#, Wenseleers T.#, Windels EM., Vanden Boer P., Kestemont D., De Meester L., Verstrepen KJ., Verstraeten N., Fauvart M.*, Michiels J.* (2016). Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nature Microbiology, 1(5):16020.
Verstraeten N.#, Knapen W.#, Kint CI., Liebens V., Van den Bergh B., Dewachter L., Michiels J., Fu Q., David C., Fierro Gutiérrez AC E., Marchal K., Beirlant J., Versées W., Hofkens J., Jansen M., Fauvart M.*, Michiels J.* (2015). Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Molecular Cell, 59(1):9-21.
Wilmaerts D., Bayoumi M., Dewachter L., Knapen W., Mika J., Hofkens J., Dedecker P., Maglia G., Verstraeten N.*, Michiels J.* (2018). The persistence-inducing toxin HokB forms dynamic pores that cause ATP leakage. mBio, 9(4):e00744-18.
Wilmaerts D., Dewachter L., De Loose P-J., Bollen C., Verstraeten N.*, Michiels J.* (2019). HokB monomerization and membrane repolarization control persister awakening. Molecular Cell, 75(5):1031-1042.
Windels EM., Michiels JE., Fauvart M., Wenseleers T., Van den Bergh B., Michiels J. (2019). Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. The ISME Journal, 13(5):1239-1251.
Copyright 2019 by BAMdesign @ All Rights Reserved